ORMDL3 and hepatocellular carcinoma: First, Western Blot and RT-qPCR were used to detect the expression differences of ORMDL3 in human normal liver cells HL-7702 and human hepatoma cells HepG2 and SMMC-7721 in the presence or absence of sorafenib (Fig. S1 A, B).